Similar Papers

Paper Title
Journal
Date
Author
Mesenchymal stem cell-derived exosome mir-342-3p inhibits metastasis and chemo-resistance of breast cancer through regulating ID4.
Shuyao Yu ... Yu Yan
Genes & Genomics | VOL. 44
Shuyao Yu, et. al.Shuyao Yu ... Yu Yan
13 Jan 2022
Abstract 548: CXCR2 controls breast cancer metastasis and chemoresistance through PI3K/AKT and COX-2 signalings.
Han Xu ... Jiao Meng
Cancer Research | VOL. 73
Han Xu, et. al.Han Xu ... Jiao Meng
15 Apr 2013
Abstract 4676: Cancer stem cell induces chemoresistance in breast cancer via macrophage migration inhibitory factor mediated activation of AKT pathway
Subhayan Das ... Aditya Parekh
Cancer Research | VOL. 79
Subhayan Das, et. al.Subhayan Das ... Aditya Parekh
01 Jul 2019
JAK/STAT3-Regulated Fatty Acid β-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance
Tianyi Wang ... Hua Yu
Cell Metabolism | VOL. 27
Tianyi Wang, et. al.Tianyi Wang ... Hua Yu
14 Dec 2017
View more papers

More From: Genes & Genomics

Paper Title
Journal
Date
Author
Correction: characteristics of insulin resistance in Korean adults from the perspective of circadian and metabolic sensing genes.
Miso S Park ... Sang-Soo Park
Genes & Genomics | VOL. -
Miso S Park, et. al.Miso S Park ... Sang-Soo Park
07 Feb 2024
Correction: Suppression of synuclein gamma inhibits the movability of endometrial carcinoma cells by PI3K/AKT/ERK signaling pathway.
Man Ni ... Yue Zhao
Genes & Genomics | VOL. -
Man Ni, et. al.Man Ni ... Yue Zhao
24 Jan 2024
Correction to: Mesenchymal stem cell-derived exosome mir-342-3p inhibits metastasis and chemo-resistance of breast cancer through regulating ID4.
Shuyao Yu ... Ligang Niu
Genes & Genomics | VOL. -
Shuyao Yu, et. al.Shuyao Yu ... Ligang Niu
16 Oct 2023
ST6GALNAC1 promotes the invasion and migration of breast cancer cells via the EMT pathway.
Yunzhao Luo ... Chuqi Lei
Genes & Genomics | VOL. 45
Yunzhao Luo, et. al.Yunzhao Luo ... Chuqi Lei
25 Sep 2023
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.